Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): China Scholarship Council Background Connexin-43 (Cx43) plays a pivotal role in intercellular communication through gap junctions. It is instrumental in propagating electrical signals and allowing ions to flow between neighboring cardiomyocytes. This synchronized electrical activity allows the heart to work as a functional syncytium. Any disruption or malfunction of Cx43 can lead to arrhythmias and other cardiac issues. Understanding the functions and regulation of Cx43 is vital in both basic research and clinical contexts. Propafenone, a class Ic antiarrhythmic drug, has shown promise in rhythm control; however, its precise impact on cardiac cellular physiology, particularly regarding Cx43, remains incompletely understood. Purpose To investigate propafenone's effect on Cx43 expression, physiology, and underlying mechanisms in cell systems. Methods Used cell lines include human embryonic kidney HEK293 cells transfected with Cx43; differentiated murine embryonic carcinoma EPI7 cells with an epithelioid morphology and visceral endoderm-like END2 cells, endogenously expressing high amounts of functional Cx43. Cx43 protein expression levels were determined by Western blot analysis, whereas immunofluorescence (IF) imaged by a Total Internal Reflection Fluorescence (TIRF) microscope was used to assess the subcellular localization of Cx43 proteins. Dye injections were used to gain insight into the effects of propafenone on Cx43 metabolic coupling. Results and Conclusion Full length Cx43 protein levels were increased after treatment with propafenone and IF microscopy showed an intracellular accumulation of Cx43 protein, both on ectopically and endogenously expressed Cx43. Propafenone did not alter Cx43 half-life, in contrast to the lysosomal inhibitor chloroquine. Finally, gap-junctional coupling was decreased by chronic propafenone treatment. We conclude that the class 1c antiarrhythmic drug propanone increases Cx43 protein expression, resulting in its intracellular accumulation, as a side effect.

Metabolic Activation and Cytotoxicity of Propafenone Mediated by CYP2D6.

Evidence for the Formation of 6Ppd-Quinone from Antioxidant 6PPD by Cytochrome P450

Computational Biotransformation Profile of Paracetamol Catalyzed by Cytochrome P450.

Stereoselective Metabolism of Propafenone by Human Liver CYP3A4 Expressed in Transgenic Chinese Hamster CHL Cells Lines.

Regioselective hydroxylation of an antiarrhythmic drug, propafenone, mediated by rat liver cytochrome P450 2D2 differs from that catalyzed by human P450 2D6

Assessment of 25 CYP2D6 alleles found in the Chinese population on propafenone metabolism in vitro.

Metabolic activation of deferiprone mediated by CYP2A6

Stereoselectivity of racemic propafenone in N-depropylation with rat liver microsomes pretreated by different inducers

Effects of DDPH on Reperfusion Induced-Arrhythmia and Cardiac Α-Adre Noceptors

Potential Inhibition of Cytochrome P450 3A4 by Propofol in Human Primary Hepatocytes.

Effects of 6PPD-Quinone on Human Liver Cell Lines as Revealed with Cell Viability Assay and Metabolomics Analysis

Effect of Cyp2d6*10 Genotype on Propafenone Pharmacodynamics in Chinese Patients with Ventricular Arrhythmia

Β-Cypermethrin and Its Metabolite 3-Phenoxybenzoic Acid Induce Cytotoxicity and Block Granulocytic Cell Differentiation in HL-60 Cells.

Metabolic activation and cytotoxicity of 4-Methylquinoline mediated by CYP3A4 and sulfotransferases in rats

Metabolic Activation and Cytotoxicity of Donepezil Induced by CYP3A4

Structure and Toxicity Characterization of Alkyl Hydroxylated Metabolites of 6PPD-Q

The Influence of Cyp2d6 Activity on the Kinetics of Propafenone Enantiomers in Chinese Subjects

Propafenone-induced connexin-43 protein accumulation and intracellular dynamics

Comparison of the Circulating Metabolite Profile of PF-04991532, a Hepatoselective Glucokinase Activator, Across Preclinical Species and Humans: Potential Implications in Metabolites in Safety Testing Assessment

Distinct Species-Specific and Toxigenic Metabolic Profiles for 6PPD and 6PPD Quinone by P450 Enzymes: Insights from In Vitro and In Silico Studies

Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae